Frontlight ResearchEarly access
Asthma trials in China
54 of 78 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 230
- Run by
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07372287 - No phaseNot yet taking people in ChinaSafety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma
- Where
- Chongqing, Guangzhou, Qingdao, Tai’an
- Age
- 18 years to 60 years
- People
- 18
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07453771 - Phase 2Not yet taking people in ChinaA Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
- Where
- Guangzhou, Shanghai
- Age
- 18 years to 65 years
- People
- 160
- Run by
- Akeso
See details and how to joinNCT07436221 - No phaseNot yet taking people in ChinaModified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome
- Where
- Hangzhou, Jinan, Zhengzhou
- Age
- 18 years to 80 years
- People
- 400
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT07352488 - Phase 3Taking peopleEfficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
- Where
- Beijing, Changzhou, Guangzhou, Huangzhou, Qingdao, Shanghai, Tongji, Xiangya, Zhongshan
- Age
- 12 years to 65 years
- People
- 736 worldwide
- Run by
- Inmunotek S.L.
See details and how to joinNCT07348302 - Phase 2Taking peopleEfficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Longbio Pharma
See details and how to joinNCT07342803 - Phase 2Taking peopleSafety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
- Where
- Nanchang
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Anhui Palo Alto Pharmaceuticals, Inc.
See details and how to joinNCT07326995 - Phase 3Taking peopleEfficacy and Safety Study of 610 in Patients With Severe Asthma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 480
- Run by
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT06323213 - Phase 2Taking peopleStudy on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
- Where
- Nanchang
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Anhui Palo Alto Pharmaceuticals, Inc.
See details and how to joinNCT07324707 - Phase 2Taking peopleA Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
- Where
- Chengdu
- Age
- 18 years and over
- People
- 200
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT06441812 - Phase 1Taking peopleA Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma
- Where
- Suzhou
- Age
- 18 years to 65 years
- People
- 12
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07015749 - Phase 3Taking peopleA Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 408
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07098403 - No phaseTaking peopleCommunity Exercise Treating Effect on Cardiopulmonary Disease Patients
- Where
- Guangzhou
- Age
- 18 years to 85 years
- People
- 200
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07154355 - Phase 2Taking peopleStudy of CM512 Injection in Subjects With Moderate-to-severe Asthma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT07011524 - No phaseTaking peopleThe Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
- Where
- Beijing, Changsha, Guangzhou, Hangzhou, Shanghai, Shenyang, Taiyuan, Zhengzhou
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Beijing Chao Yang Hospital
See details and how to joinNCT07136025 - No phaseNot yet taking people in ChinaVibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion
- Where
- Hangzhou
- Age
- 12 years to 50 years
- People
- 200
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07114107 - No phaseEnrolling by invitationA Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07114133 - Phase 3Not yet taking people in ChinaA Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)
- Where
- Nanjing
- Age
- 14 years and over
- People
- 198
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06895460 - No phaseEnrolling by invitationIntervention Effects of High-intensity Tai Chi in Mild or Moderate Asthma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 35
- Run by
- Yufen Wu, MD
See details and how to joinNCT06728904 - Phase 2Taking peopleStudy of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 252
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06775340 - Phase 2Not yet taking people in ChinaClinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT06940700 - Phase 3Taking peopleClinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
- Where
- Guangzhou
- Age
- 12 years to 75 years
- People
- 504
- Run by
- Shanghai Mabgeek Biotech.Co.Ltd
See details and how to joinNCT06837922 - No phaseNot yet taking people in ChinaPulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy
- Where
- Beijing
- Age
- 18 years and over
- People
- 26
- Run by
- Jingen Xia
See details and how to joinNCT06891274 - No phaseTaking peopleFeNO Detection in Asthma Diagnosis: A New Technology Approach
- Where
- Shanghai, Wuxi
- Age
- 18 years and over
- People
- 170
- Run by
- Novlead Inc.
See details and how to joinNCT06852911 - Phase 2Enrolling by invitationA Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
- Where
- Beijing
- Age
- 18 years and over
- People
- 309
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06820749